Hisanori Kobayashi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM.
Journal: International journal of hematology
Published: August 27, 2024
Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression.
Journal: Psychiatry and clinical neurosciences
Published: December 21, 2021
Design of Over-1000 nm Near-Infrared Fluorescent Polymeric Micellar Nanoparticles by Matching the Solubility Parameter of the Core Polymer and Dye.
Journal: ACS nanoscience Au
Published: October 04, 2021
Effects of hydrophilic/hydrophobic blocks ratio of PEG-b-PLGA on emission intensity and stability of over-1000 nm near-infrared (NIR-II) fluorescence dye-loaded polymeric micellar nanoparticles.
Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry
Published: September 24, 2021
Designing highly emissive over-1000 nm near-infrared fluorescent dye-loaded polystyrene-based nanoparticles for in vivo deep imaging.
Journal: RSC advances
Published: February 07, 2021
Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with Schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: January 12, 2021
Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data.
Journal: Rheumatology and therapy
Published: October 08, 2020
Clinical response among golimumab-treated Japanese patients with rheumatoid arthritis by number of previous biologic therapies: Real-world evidence from post-hoc analysis of post-marketing surveillance data.
Journal: Modern rheumatology
Published: July 18, 2020
Effectiveness of golimumab in rheumatoid arthritis patients with inadequate response to first-line biologic therapy: Results from a Japanese post-marketing surveillance study.
Journal: Modern rheumatology
Published: July 18, 2020
The Effects of Paliperidone Palmitate 1 Month on the Employment Status and Social Functioning of Patients with Schizophrenia.
Journal: Innovations in clinical neuroscience
Published: June 18, 2020
Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical Setting.
Journal: Innovations in clinical neuroscience
Published: February 22, 2020
Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data.
Journal: Rheumatology and therapy
Published: December 10, 2019
Last Updated: 09/26/2026